On using the standard gamble to determine utilities for uncertain health states.

Assessing patient preferences for treatment options and process of care in inflammatory bowel disease: a critical review of quantitative data. Patient (2013) 0.87

Can the standard gamble be used to determine utilities for uncertain health states? An example using postoperative maintenance therapy in Crohn's disease. Med Decis Making (2000) 1.51

Historical epidemiology of hepatitis C virus (HCV) in select countries - volume 2. J Viral Hepat (2015) 1.22

Sporadic adenomatous polyp regression with exisulind is effective but toxic: a randomised, double blind, placebo controlled, dose-response study. Gut (2005) 1.14

Halitosis and gastroesophageal reflux disease: a possible association. Oral Dis (2007) 1.02

The present and future disease burden of hepatitis C virus (HCV) infections with today's treatment paradigm - volume 2. J Viral Hepat (2015) 1.02

Cost effectiveness of mass screening for coeliac disease is determined by time-delay to diagnosis and quality of life on a gluten-free diet. Aliment Pharmacol Ther (2010) 0.99

Identification of colorectal adenomas by a quantitative immunochemical faecal occult blood screening test depends on adenoma characteristics, development threshold used and number of tests performed. Aliment Pharmacol Ther (2009) 0.93

Assessment of the underestimation of childhood diarrhoeal disease burden in Israel. Epidemiol Infect (2010) 0.90

Strategies to manage hepatitis C virus (HCV) infection disease burden - volume 2. J Viral Hepat (2015) 0.89

Can patients at high risk for significant colorectal neoplasms and having normal quantitative faecal occult blood test postpone elective colonoscopy? Aliment Pharmacol Ther (2009) 0.88

Clinical trial: evaluation of a clinical decision-support model for upper abdominal complaints in primary-care practice. Aliment Pharmacol Ther (2007) 0.77

[How to improve the outcome of cohort studies?]. Harefuah (2011) 0.75

[How to build a predictive model and how to predict the individual outcome?]. Harefuah (2012) 0.75

[Effect of low-dose heparin on the peripheral platelet count]. Harefuah (1986) 0.75